Quality of life study for people with meningioma
Part of Brain & nervous system, Cancer clinical trials.
This study tests a French questionnaire about quality of life for people with meningioma, a type of brain tumor. It aims to better understand how the disease affects daily life and to improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with a meningioma (a usually non-cancerous brain tumor) based on imaging or surgery.
- You are not pregnant or breastfeeding.
- You are not in prison or under compulsory psychiatric care.
- You can read and understand French well enough to fill out questionnaires on your own.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a French version of a questionnaire that measures quality of life in people with meningioma. Participation involves filling out the questionnaire to help doctors better understand how the tumor affects your daily life.
This study looks at how your tumor's genes, personal health habits, and other factors affect your long-term health after a meningioma diagnosis. You'll be asked to complete surveys about your health and experiences—no new treatments or procedures are involved.
This study looks at how your quality of life changes over time after being diagnosed with a brain tumor called glioma. It may help doctors better understand what support or treatments improve day-to-day well-being.
This study looks at how breast cancer that has spread to the brain affects your quality of life. It aims to understand your experiences so doctors can better support patients like you.
This study is developing a new questionnaire to measure the symptoms and impact of Chiari malformation and syringomyelia. By participating, you can help create a better tool for doctors to understand and treat these conditions.
This study asks people with neuroendocrine tumors to report how they’re doing, including quality of life and quality of care. Your answers can help doctors and hospitals understand what support works best.
Hear when a new Intracranial Meningioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.